Small Molecules

05/10/2023 | 3 min read

Endogena Therapeutics CEO Matthias Steger discusses fast track FDA approval for EA-2353, a new drug for the treatment of retinitis pigmentosa

Discovery & Development Formulation

05/09/2023 | 3 min read

An insight into the research fuelling developments for universal cancer immunotherapies

Discovery & Development Formulation

04/19/2023 | Jamie Irvine | 2 min read

Researchers use genome mining and bioengineering techniques to develop sustainable saponin-based vaccine adjuvants

Business & Regulation Profession

04/17/2023 | Stephanie Vine

The wait is over. Our annual celebration of the pharma industry’s most influential individuals has returned!

Manufacture Advanced Medicine

04/12/2023 | Rob Coker | 5 min read

Oligonucleotides are a complex but promising new modality in therapeutics. Director of New Modalities at CatSci Nigel Richardson explains why.

Discovery & Development Drug Discovery

03/21/2023 | Arthur T Suckow | 5 min read

A start up company explains how their platform is helping to boost RNA therapeutics.

Discovery & Development Drug Discovery

03/17/2023 | Rob Coker | 2 min read

These fungi have some real nerve (developing properties).

Manufacture Small Molecules

03/02/2023 | Charles Johnson | 4 min read

Pipelines are changing, and chemical complexity is on the rise. What can pharma manufacturers do about it?

Business & Regulation Business Practice

02/01/2023 | Stephanie Vine | 4 min read

Lawsuit from GenBioPro is the first of its kind – but other cases are likely to follow.

Discovery & Development Drug Discovery

12/01/2022 | Angus Stewart | 9 min read

Water is the giver of life, but could it be a giver of untold medicines too?